NCT05385211View on ClinicalTrials.gov

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2022

Primary Completion Date

August 30, 2023

Study Completion Date

August 30, 2023

Conditions
Type 1 DiabetesExocrine Pancreatic Insufficiency
Interventions
OTHER

Frequency of hypoglycemia in people with type 1 diabetes and exocrine pancreatic insufficiency

Blood samplings; Glucose monitoring; CFTR variants

Trial Locations (1)

H2

Institut de recherches cliniques de Montréal, Montreal

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

collaborator

Institut de Recherches Cliniques de Montreal

OTHER

lead

Ciusss de L'Est de l'Île de Montréal

OTHER